Adherium Limited

ADR

AU000000ADR1

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 02:10:10 2024-04-22 am EDT			5-day change	1st Jan Change
0.029 ^AUD	0.00%		-23.68%	-48.21%

Apr. 15	Adherium’s Hailie Smartinhaler Secures FDA Approval for Use with AstraZeneca's Airsupra and Breztri Inhalation Devices	MT
Apr. 03	Adherium Signs Partnership Deal with Rimidi for Asthma Medication	MT

Adherium Limited Announces Conclusion of Robert Spurr's Assignment as Interim CFO

May 29, 2022 at 08:02 pm EDT

Adherium Limited announced that Robert Spurr's interim CFO assignment has concluded and recruiting for the backfill of this Melbourne-based position is progressing.

Latest news about Adherium Limited

Adherium’s Hailie Smartinhaler Secures FDA Approval for Use with AstraZeneca's Airsupra and Breztri Inhalation Devices	Apr. 14	MT
Adherium Signs Partnership Deal with Rimidi for Asthma Medication	Apr. 02	MT
Adherium's Research Collaboration with US Intermountain, CareCentra Enrolls First Patient	Mar. 19	MT
Adherium Secures AU$1.5 Million R&D Tax Rebate for Fiscal Year 2023	Mar. 07	MT
Adherium Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28	CI
Adherium Appoints CEO	Jan. 31	MT
Adherium Limited Announces Resignation of Rick Legleiter as Chief Executive Officer	Jan. 15	CI
Adherium Limited Appoints Lou Panaccio as Executive Chairman of the Board	Jan. 15	CI
Adherium Limited Announces Change of Company Address	Jan. 10	CI
Adherium and NuvoAir Medical Forge Partnership for Improved Patient Outcomes	Jan. 09	MT
Adherium Completes Initial Delivery of Hailie Smart Inhaler Sensors to US Intermountain Health; Shares Jump 6%	Dec. 17	MT
Adherium Completes 1-for-15 Share Consolidation	Dec. 07	MT
Adherium Confirms Enrolment of First Patients at SENTA Partners	Nov. 21	MT
Adherium Launches Next-Generation Respiratory Sensors	23-10-09	MT
Adherium Secures First Patients with US Physician Group	23-09-25	MT
Adherium Enters Partnership for Rollout of Patient Monitoring Platform in US	23-09-18	MT
Adherium Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-30	CI
Adherium Limited Announces Change of Company Address	23-08-30	CI
Adherium Signs Deal to Integrate Respiratory Platform with US Partner	23-08-04	MT
Adherium Gears Up to Commercialize Monitoring Platform in the US	23-07-27	MT
Adherium Limited Announces Resignation of Mark Licciardo as Joint Company Secretary	23-07-06	CI
Adherium Limited Announces Executive Changes	23-05-03	CI
Adherium Secures US FDA Clearance for Use of Sensor on Teva Inhalers	23-03-23	MT
Adherium Limited Receives U.S. FDA 510(k) Clearance for Teva's Proair® and Albuterol Sulphate Inhaler Users to Remotely Monitor Physiological Parameters	23-03-22	CI
Adherium Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-26	CI

Adherium Limited is a New Zealand-based international respiratory e-health company. The Company is focused on patient medication adherence, remote monitoring and data management solutions for patients, payers and providers. The Companyâs Hailie sensor technology and cloud-based data platform provides real-time feedback on patients' use of inhaled medication, enabling optimal management of difficult-to-treat and severe asthma and chronic obstructive pulmonary disease (COPD), and reduces direct and indirect healthcare costs. The Companyâs technologies include The Hailie Remote Patient Management (RPM) Solution, The Hailie Sensors and The Hailie Solution. Its Hailie solution is a cloud-based platform, which captures medication use data from Food and Drug Administration (FDA)-cleared Bluetooth enabled sensors, which wrap around patient inhalers and provide real-time feedback to patients via the Hailie application and to their physicians via the Hailie portal.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-08-27 - Q4 2024 Earnings Release (Projected)

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
ADHERIUM LIMITED	-48.21%	6.35M
THERMO FISHER SCIENTIFIC	+8.35%	209B
DANAHER CORPORATION	+9.41%	175B
INTUITIVE SURGICAL, INC.	+11.75%	131B
BOSTON SCIENTIFIC CORPORATION	+19.34%	99.98B
SIEMENS HEALTHINEERS AG	-0.84%	61.12B
EDWARDS LIFESCIENCES CORPORATION	+15.08%	52.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-2.10%	46.5B
AGILENT TECHNOLOGIES, INC.	+0.10%	39.24B
GE HEALTHCARE TECHNOLOGIES INC.	+11.50%	38.47B

Other Advanced Medical Equipment & Technology